Postoperative hyperprolactinaemia and early recurrence rate in breast cancer

Prediction of Recurrence in Operable Breast Cancer by Postoperative Changes in Prolactin Secretion

“…PRL has been proven to be a growth factor for breast carcinoma [5], Therefore, from a biological point of view, the lack of surgery-induced PRL increase could constitute a positive biological event in breast carcino ma. In contrast, preliminary data [6,7] seem to show that surgery-induced hyperprolactinemia is paradoxi cally associated with a better prognosis in terms of breast cancer relapse. The aim of the present study was to ana lyze the long-term results concerning the influence of postoperative changes in PRL secretion on the relapse rate in operable breast carcinoma.…”

Prediction of Recurrence in Operable Breast Cancer by Postoperative Changes in Prolactin Secretion

“…PRL has been proven to be a growth factor for breast carcinoma [5], Therefore, from a biological point of view, the lack of surgery-induced PRL increase could constitute a positive biological event in breast carcino ma. In contrast, preliminary data [6,7] seem to show that surgery-induced hyperprolactinemia is paradoxi cally associated with a better prognosis in terms of breast cancer relapse. The aim of the present study was to ana lyze the long-term results concerning the influence of postoperative changes in PRL secretion on the relapse rate in operable breast carcinoma.…”

Hydroxyl safflower yellow B combined with doxorubicin inhibits the proliferation of human breast cancer MCF‑7 cells

“…Breast cancer treatment uses a comprehensive treatment model that includes surgery and chemotherapy (3). The high postoperative recurrence rate and post-surgical complications within a short period following breast cancer surgery are significant (4,5). Therefore, increased attention has been focused on further elucidating the pathogenesis of breast cancer to discover and develop novel treatment methods.…”

Prediction of Recurrence in Operable Breast Cancer by Postoperative Changes in Prolactin Secretion

“…PRL has been proven to be a growth factor for breast carcinoma [5], Therefore, from a biological point of view, the lack of surgery-induced PRL increase could constitute a positive biological event in breast carcino ma. In contrast, preliminary data [6,7] seem to show that surgery-induced hyperprolactinemia is paradoxi cally associated with a better prognosis in terms of breast cancer relapse. The aim of the present study was to ana lyze the long-term results concerning the influence of postoperative changes in PRL secretion on the relapse rate in operable breast carcinoma.…”

Hydroxyl safflower yellow B combined with doxorubicin inhibits the proliferation of human breast cancer MCF‑7 cells

“…Breast cancer treatment uses a comprehensive treatment model that includes surgery and chemotherapy (3). The high postoperative recurrence rate and post-surgical complications within a short period following breast cancer surgery are significant (4,5). Therefore, increased attention has been focused on further elucidating the pathogenesis of breast cancer to discover and develop novel treatment methods.…”

Prediction of Recurrence in Operable Breast Cancer by Postoperative Changes in Prolactin Secretion

“…PRL has been proven to be a growth factor for breast carcinoma [5], Therefore, from a biological point of view, the lack of surgery-induced PRL increase could constitute a positive biological event in breast carcino ma. In contrast, preliminary data [6,7] seem to show that surgery-induced hyperprolactinemia is paradoxi cally associated with a better prognosis in terms of breast cancer relapse. The aim of the present study was to ana lyze the long-term results concerning the influence of postoperative changes in PRL secretion on the relapse rate in operable breast carcinoma.…”

Hydroxyl safflower yellow B combined with doxorubicin inhibits the proliferation of human breast cancer MCF‑7 cells

“…Breast cancer treatment uses a comprehensive treatment model that includes surgery and chemotherapy (3). The high postoperative recurrence rate and post-surgical complications within a short period following breast cancer surgery are significant (4,5). Therefore, increased attention has been focused on further elucidating the pathogenesis of breast cancer to discover and develop novel treatment methods.…”